Contract 75P00226P00004
Valneva USA, Inc. · Department Of Health And Human Services · January 6, 2026
Valneva USA, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of The Assistant Secretary For Administration) on January 6, 2026 for an undisclosed amount of work in pharmaceutical preparation manufacturing. Performance is in Bethesda, MD. It was awarded under a small business set-aside. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 9, 2026.
Contract details
- PIID
- 75P00226P00004
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Competed Under Sap
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Bethesda, MD
- First action
- January 6, 2026
- Latest action
- January 9, 2026
Description
JAPANESE ENCEPHALITIS VACCINE TO PROTECT STATE DEPARTMENT PERSONNEL AND THEIR FAMILIES.
Modification timeline
-
January 9, 2026Mod P00001 · Supplemental Agreement For Work Within Scope$0
-
January 6, 2026Base award$172.2K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 27, 2026 | $92.33M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75P00226P00004?
Contract 75P00226P00004 is a federal contract awarded to Valneva USA, Inc. by Department Of Health And Human Services on January 6, 2026 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75P00226P00004?
Valneva USA, Inc. won contract 75P00226P00004 from Department Of Health And Human Services.
How much is contract 75P00226P00004 worth?
Contract 75P00226P00004 has no obligated funds in the available record. It may be a pre-award placeholder or an indefinite-delivery vehicle awaiting task orders.